Australia Diabetes Market Forecasts and Company Analysis 2024-2032, Novo Nordisk, Eli Lilly, Roche, Abbott Laboratories, Insuletn, Dexcom, Medtronic, Ypsomed
November 25, 2024 10:16 ET
|
Research and Markets
Dublin, Nov. 25, 2024 (GLOBE NEWSWIRE) -- The "Australia Diabetes Market Forecast Report by Type, End User and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's...
Spain Diabetes Market Report 2024-2032: A $1.32 Billion Industry Opportunity with Insights on Prevalence Trends, Demographical Breakup, Diagnosis and Treatment
October 17, 2024 04:12 ET
|
Research and Markets
Dublin, Oct. 17, 2024 (GLOBE NEWSWIRE) -- The "Spain Diabetes Market Report: 2024-2032" report has been added to ResearchAndMarkets.com's offering.The Spain diabetes market size reached US$ 947.9...
China Diabetes Market Report 2024-2032: China Currently has the Highest Number of Diabetics in the World
July 22, 2024 04:22 ET
|
Research and Markets
Dublin, July 22, 2024 (GLOBE NEWSWIRE) -- The "China Diabetes Market Report: 2024-2032" report has been added to ResearchAndMarkets.com's offering.The China diabetes market size reached US$ 4.7...
Dementia with Diabetes Pipeline Therapeutics Market Report 2024: Comprehensive Insights About 5+ Companies and 5+ Pipeline Drugs
July 17, 2024 09:09 ET
|
Research and Markets
Dublin, July 17, 2024 (GLOBE NEWSWIRE) -- The "Dementia with Diabetes - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
Global Diabetes Drug Analysis Report 2024: A $107.02 Billion Market by 2032 Driven by Novo Nordisk, AstraZeneca, Biocon, Sanofi, Eli Lilly, Johnson & Johnson, Bristol Myers Squibb, Novartis
May 24, 2024 07:07 ET
|
Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Global Diabetes Drug Market Report by Drug class, Diabetes types, Route of Administration, Distribution Channels, Region and Company Analysis 2024-2032"...
Global Smart Insulin Pens Market Report 2024, Featuring Profiles of Companion Medical, Emperra, Eli Lilly, Bigfoot Biomedical, Diamesco, Pendiq, Medtronic, Diabnext, Diabecare and Capillary Biomedical
March 25, 2024 12:13 ET
|
Research and Markets
Dublin, March 25, 2024 (GLOBE NEWSWIRE) -- The "Global Smart Insulin Pens Market" report has been added to ResearchAndMarkets.com's offering.The global smart insulin pens market accounted for USD...
Global Antidiabetics Market Report 2024 - A $313.9 Billion Market by 2034, with CAGR of 10.9% During 2024-2034
March 18, 2024 05:10 ET
|
Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Global Antidiabetics Market by Product Type, by Application, by Distribution channel, and By Region" report has been added to ...
Cell Therapies for Type 1 Diabetes: 2023-2030 Industry Outlook Featuring Analysis of Leading Players Novo Nordisk, Sanofi, Vertex Pharmaceuticals, Sernova, and Throne Biotechnologies
January 30, 2024 04:49 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Cell Therapies for Type 1 Diabetes (2023 Edition): Global and Country Analysis By Epidemiology, Pipeline and Target Market Assessment" report has been...
Key Vendors AdvaCare Pharma, Becton Dickinson, and Nipro Corp. Lead Global Insulin Syringes Market
September 22, 2023 06:18 ET
|
Research and Markets
Dublin, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The "Global Insulin Syringes Market 2022-2026" report has been added to ResearchAndMarkets.com's offering. The global Insulin Syringes Market is on the...
Global Diabetes Epidemic: Unprecedented Economic Burden of $966 Billion in 2021 Underscores Urgency for Innovative Therapeutics and Diagnostics
September 18, 2023 07:38 ET
|
Research and Markets
Dublin, Sept. 18, 2023 (GLOBE NEWSWIRE) -- The "Global Markets for Diabetes Therapeutics and Diagnostics" report has been added to ResearchAndMarkets.com's offering. The latest market analysis...